Jan van de Kassteele

Author

National Institute for Public Health and the Environment ORCID

Also Known As

J VAN DE KASSTEELE, J VAN KASSTEELE, J van de Kassteele, J. VAN DE KASSTEELE, J. Van de Kassteele, J. van de Kassteele, Jan Polman, Jan Van De Kassteele, Jan Van de Kassteele, Jan van de Kassteele

120

Publications

Citations

H-Index

108

Concepts

All Affiliations

National Institute for Public Health and the Environment University Medical Center Utrecht Utrecht University Wageningen University & Research Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Jan van de Kassteele is an author at National Institute for Public Health and the Environment specializing in medicine, epidemiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	1.2K
2	Engineering	6	6	209
3	Health Sciences	2	2	81
4	Education	1	1	14
5	Management	1	1	30

Jan van de Kassteele

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season Adam Meijer, Angie Lackenby, Olav Hungnes, Emerging infectious diseases Viral EvolutionVirus EpidemiologyViral Pathogenesis2007-08 Winter SeasonHomogeneous Subgroup	2009	361
Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season Adam Meijer, Angie Lackenby, Olav Hungnes, Emerging infectious diseases	2009	311
Mortality Attributable to 9 Common Infections: Significant Effect of Influenza A, Respiratory Syncytial Virus, Influenza B, Norovirus, and Parainfluenza in Elderly Persons Liselotte van Asten, Cees van den Wijngaard, Wilfrid van Pelt, The Journal of Infectious Diseases	2012	195
Determinants for HPV vaccine uptake in the Netherlands: A multilevel study Marc Rondy, Alies van Lier, Jan van de Kassteele, Vaccine VaccinationVaccine SafetyPreventive MedicineCervical CancerHuman Papillomavirus Vaccines	2009	123
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021 Brechje de Gier, Stijn P. Andeweg, Rosa Joosten, Eurosurveillance	2021	88
Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial Daan Barug, Inge Pronk, Marlies A. van Houten, The Lancet Infectious Diseases VaccinationVaccine SafetyMaternal ImmunizationMedicinePediatrics	2019	87
Population-based serology reveals risk factors for RSV infection in children younger than 5 years Stijn P. Andeweg, Rutger M. Schepp, Jan van de Kassteele, Scientific Reports	2021	85
Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections Tjallie van der Kooi, Hugo Sax, Didier Pittet, Intensive Care Medicine Preventive MedicineHospital InfectionsAntibioticsHealthcare-associated InfectionPatient Safety	2017	77
Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model Agnetha Hofhuis, Jan van de Kassteele, Hein Sprong, PLoS ONE	2017	76
Nowcasting the Number of New Symptomatic Cases During Infectious Disease Outbreaks Using Constrained P-spline Smoothing Jan van de Kassteele, Paul H.C. Eilers, Jacco Wallinga Epidemiology Epidemiological DynamicDiagnosisComputational EpidemiologyInfectious Disease ModellingData Science	2019	74

Page 1